trial · primary record
Aceclidine+Brimonidine combination ophthalmic solution
Presbyopia
| Phase | Phase 3 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 229 |
| Primary completion | 2024-01-24 |
| Primary endpoint | Percentage of Participants With a ≥ 3-line Improvement in Near Vision and no Loss ≥ 5 Letters Distance Vision |
| Registry ID | NCT05728944 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:33:12.951Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05728944
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.